SIO GENE THERAPIES INC - COMMON (SIOX)

CUSIP: 829399104

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COMMON
Total 13F shares
18,370,445
Share change
-2,171,408
Total reported value
$39,863,000
Put/Call ratio
30%
Price per share
$2.17
Number of holders
49
Value change
-$6,410,657
Number of buys
22
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 829399104?
CUSIP 829399104 identifies SIOX - SIO GENE THERAPIES INC - COMMON in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIO GENE THERAPIES INC - COMMON (SIOX) as of Q3 2021

As of 30 Sep 2021, SIO GENE THERAPIES INC - COMMON (SIOX) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,370,445 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, Rubric Capital Management LP, VANGUARD GROUP INC, Hudson Bay Capital Management LP, Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, Prosight Management, LP, BANK OF MONTREAL /CAN/, GSA CAPITAL PARTNERS LLP, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.